Modern management of achalasia

Current Opinion in Gastroenterology

Volumn 26, Issue 4, 2010, Pages 384-388

  Moawad, Fouad J ^a   Wong, Roy K H ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Achalasia; Management; Myotomy; Pneumatic dilation

Indexed keywords

BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; NITRIC ACID DERIVATIVE; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; DIZZINESS; ESOPHAGUS ACHALASIA; HEADACHE; HUMAN; HYPOTENSION; LONG TERM CARE; MYOTOMY; PERIPHERAL EDEMA; QUALITY OF LIFE; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME; CATHETERIZATION; ESOPHAGEAL ACHALASIA; ESOPHAGOSCOPY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

BALLOON DILATATION; BOTULINUM TOXIN TYPE A; CALCIUM CHANNEL BLOCKERS; COMORBIDITY; ESOPHAGEAL ACHALASIA; ESOPHAGOSCOPY; HUMANS; NEUROMUSCULAR AGENTS; NITRATES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; BOTULINUM TOXINS, TYPE A; CATHETERIZATION;

EID: 77954143120     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32833aaf4a     Document Type: Review

References (36)

1. Willis T. Pharmaceutics rationalis: Sive diatriba de medicamentorum oper-ationibus in humano corpore. Ondon: Hagae-Comitis; 1674.
2. Walzer N, Hirano I. Achalasia. Gastroenterol Clin North Am 2008; 37:807-825.
3. Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 2009; 54:2303-2311.
4. Annese V, Bassotti G, Coccia G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. Gismad achalasia study group. Gut 2000; 46:597-600.
5. Kroupa R, Hep A, Dolina J, et al. Combined treatment of achalasia- botulinum toxin injection followed by pneumatic dilatation: long-term results. Dis Esophagus 2009 [Epub ahead of print].
6. Cash BD, Wong RK. Historical perspective of achalasia. Gastrointest Endosc Clin N Am 2001; 11:221-234.
7. Kadakia SC, Wong RK. Pneumatic balloon dilation for esophageal achalasia. Gastrointest Endosc Clin N Am 2001; 11:325-346.
8. Farhoomand K, Connor JT, Richter JE, et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004; 2:389-394.
9. Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53:629-633.
10. Campos GM, Vittinghoff E, Rabl C, et al. A systematic review and meta-analysis. Ann Surg 2009; 249:45-57.
11. Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 2010; 8:30-35.
12. Chuah SK, Hu TH, Wu KL, et al. Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation. J Gastrointest Surg 2009; 13:862-867.
13. Ghoshal UC, Kumar S, Saraswat VA, et al. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 2004; 99:2304-2310.
14. Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006; 4:580-587.
15. Tanaka Y, Iwakiri K, Kawami N, et al. Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia. J Gastroenterol 2009 [Epub ahead of print].
16. Parkman HP, Reynolds JC, Ouyang A, et al. Pneumatic dilatation or esopha-gomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci 1993; 38:75-85.
17. Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103:1732-1738.
18. Dagli U, Kuran S, Savas N, et al. Factors predicting outcome of balloon dilatation in achalasia. Dig Dis Sci 2009; 54:1237-1242.
19. Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol 2008; 2:435-445.
20. Wang L, Li YM, Li L, et al. A systematic review and meta-analysis of the chinese literature for the treatment of achalasia. World J Gastroenterol 2008; 14:5900-5906.
21. Deb S, Deschamps C, Allen MS, et al. Laparoscopic esophageal myotomy for achalasia: factors affecting functional results. Ann Thorac Surg 2005; 80:1191-1194.
22. Rosemurgy A, Villadolid D, Thometz D, et al. Laparoscopic heller myotomy provides durable relief from achalasia and salvages failures after botox or dilation. Ann Surg 2005; 241:725-733.
23. Smith CD, Stival A, Howell DL, et al. Endoscopic therapy for achalasia before heller myotomy results in worse outcomes than heller myotomy alone. Ann Surg 2006; 243:579-584.
24. Bonatti H, Hinder RA, Klocker J, et al. Long-term results of laparoscopic heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg 2005; 190:874-878.
25. Kilic A, Schuchert MJ, Pennathur A, et al. Long-term outcomes of laparoscopic heller myotomy for achalasia. Surgery 2009; 146:826-831.
26. Zaninotto G, Costantini M, Rizzetto C, et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg 2008; 248:986-993.
27. Beckingham IJ, Callanan M, Louw JA, et al. Laparoscopic cardiomyotomy for achalasia after failed balloon dilatation. Surg Endosc 1999; 13:493-496.
28. Richardson WS, Willis GW, Smith JW. Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc 2003; 17:696-698.
29. Horgan S, Hudda K, Eubanks T, et al. Does botulinum toxin injection make esophagomyotomy a more difficult operation? Surg Endosc 1999; 13:576-579.
30. Leyden JE, Moss AC, MacMathuna P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev 2006; CD005046.
31. Snyder CW, Burton RC, Brown LE, et al. Multiple preoperative endoscopic interventions are associated with worse outcomes after laparoscopic heller myotomy for achalasia. J Gastrointest Surg 2009 [Epub ahead of print].
32. Cowgill SM, Villadolid DV, Al-Saadi S, et al. Difficult myotomy is not determined by preoperative therapy and does not impact outcome. JSLS 2007; 11:336-343.
33. Tsuboi K, Omura N, Yano F, et al. Preoperative dilatation does not affect the surgical outcome of laparoscopic heller myotomy and dor fundoplication for esophageal achalasia. Surg Laparosc Endosc Percutan Tech 2009; 19:98-100.
34. Rebecchi F, Giaccone C, Farinella E, et al. Randomized controlled trial of laparoscopic heller myotomy plus dor fundoplication versus nissen fundoplication for achalasia: long-term results. Ann Surg 2008; 248:1023-1030.
35. Schuchert MJ, Luketich JD, Landreneau RJ, et al. Minimally invasive surgical treatment of sigmoidal esophagus in achalasia. J Gastrointest Surg 2009; 13:1029-1035; discussion 1035-1026.
36. Scott PD, Harold KL, Heniford BT, et al. Results of laparoscopic heller myotomy for extreme megaesophagus: an alternative to esophagectomy. Surg Laparosc Endosc Percutan Tech 2009; 19:198-200.